Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency. | Allergol Int | 2023 | 37169642 | PubTator, text mining | PubMed |
| Changes in the body fluids proteome as a reflection of the physiological effects of dry immersion. | Front Physiol | 2023 | 37168223 | PubTator, text mining | PubMed |
| The under-appreciated world of the serpin family of serine proteinase inhibitors. | EMBO Mol Med | 2023 | 37158379 | PubTator, text mining | PubMed |
| A Japanese patient with hereditary angioedema caused by deep intron variation in the SERPING1 gene. | J Dermatol | 2023 | 37157851 | PubTator, text mining | PubMed |
| Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus. | Front Immunol | 2023 | 37153614 | PubTator, text mining | PubMed |
| "Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions. | Front Cardiovasc Med | 2023 | 37153474 | PubTator, text mining | PubMed |
| A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom. | J Allergy Clin Immunol Pract | 2023 | 37146882 | PubTator, text mining | PubMed |
The impact of puberty on the onset, frequency, location, and severity of attacks in hereditary angioedema due to C1-inhibitor deficiency: A survey from the Italian Network for Hereditary and Acquired Angioedema (ITACA). | Front Pediatr | 2023 | 37144145 | PubTator, text mining | PubMed |
| Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor. | J Asthma Allergy | 2023 | 37124440 | PubTator, text mining | PubMed |
| Rituximab in the Treatment of Acquired Angioedema Secondary to Marginal Zone Lymphoma of the Spleen. | Cureus | 2023 | 37123708 | PubTator, text mining | PubMed |
| Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway. | J Med Chem | 2023 | 37120845 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the fragility of male spermatogenic cells to Zika virus-induced complement activation. | Nat Commun | 2023 | 37120617 | PubTator, text mining | PubMed |
| Successful treatment of post-pericardiotomy syndrome via C1 inhibitor replacement therapy in a hereditary angioedema patient with Marfan syndrome. | Turk J Pediatr | 2023 | 37114700 | PubTator, text mining | PubMed |
Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA). | Vaccines (Basel) | 2023 | 37112764 | PubTator, text mining | PubMed |
Coronavirus Disease 2019 and Primary Antibody Deficiencies. Comment on Milota et al. Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens 2023, 12, 109. | Pathogens | 2023 | 37111418 | PubTator, text mining | PubMed |
| Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies. | Molecules | 2023 | 37110557 | PubTator, text mining | PubMed |
| Acquired Angioedema in Selected Neoplastic Diseases. | Medicina (Kaunas) | 2023 | 37109602 | PubTator, text mining | PubMed |
| Pediatric Angioedema without Wheals: How to Guide the Diagnosis. | Life (Basel) | 2023 | 37109550 | PubTator, text mining | PubMed |
| By using machine learning and in vitro testing, SERPINH1 functions as a novel tumorigenic and immunogenic gene and predicts immunotherapy response in osteosarcoma. | Front Oncol | 2023 | 37091161 | PubTator, text mining | PubMed |
| A Case Report of Losartan Induced Angioedema. | Cureus | 2023 | 37090415 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=29